Selloff is extremely disconcerting.
Not sure if there is a connection, but Rigel has new plan for a P III with fostamatinib in ITP. That could be a new long term competitor for promacta. No big deal but at least surprising...to me
LGND is always taken down before positive catalysts are about to happen. So the other way to look at it: good things are on the horizon.
Sentiment: Strong Buy
Is there any negative news on LGND I'm missing? Stock has lost $3 since late August. I'm still long and can't understand lack news causing sell-off.
Manipulated with extremely low volume
Knott and Berkman both sold a significant amount of shares recently...may have something to do with it.